选择性光交换性G蛋白结合受体的性激动剂
Prashant Donthamsetti1, David B Konrad2, Belinda Hetzler3
1Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, United States.
Journal of the American Chemical Society
|June 11, 2021
概括
研究人员开发了aBINA,一种新型的可光切换的性激动剂. 这种精确药物选择性地使用光激活G蛋白结合受体2 (mGluR2), 提供新的治疗潜力.
科学领域:
- 药理学
- 生物化学
- 分子生物学
背景情况:
- G蛋白结合受体 (GPCR) 是主要的药物点,但它们的相似性和复杂的激活动态带来了挑战.
- 光药学使用光激活分子来控制药物作用,提供时间和空间精度.
- 现有的光药学工具包括光激剂/对抗剂 (非选择性) 和光调节剂 (间接控制).
研究的目的:
- 为选择性和直接控制GPCR活性设计可光切换的性激动剂.
- 开发一种针对GPCR和相关信号蛋白的新型精密药物.
主要方法:
- 将可光异构的阿佐纳入GPCR联体,以产生可切换光的活性.
- 针对非保留部位的异质调节器的设计,以提高选择性.
- 开发和测试aBINA,一种可光切换的甲基谷氨酸受体2 (mGluR2) 的全精激剂.
主要成果:
- 一种可光切换的性激动剂aBINA的成功设计和合成.
- 证明aBINA可以选择性地激活Gi/o结合的转基因谷氨酸受体2 (mGluR2).
- 在光刺激时,aBINA提供直接的受体激活,独立于内源性配体.
结论:
- aBINA代表了GPCR的一种新型精密药物.
- 这种方法可以对GPCR信号进行选择性和直接的光控制.
- 开发的技术有望治疗涉及GPCR和其他信号蛋白的疾病.
相关概念视频
Activation and Inactivation of G Proteins
8.2K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.2K
Transducer Mechanism: G Protein–Coupled Receptors
3.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.1K
G-protein Coupled Receptors
126.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
126.7K
G Protein-coupled Receptors
14.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.5K
GPCR Desensitization
7.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.0K
The Two-State Receptor Model
2.7K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.7K


